Impact of a Computerized Guidelines on the Management of Hypertension and Diabetes (ASTI)

This study has been completed.
Sponsor:
Information provided by:
Société de Formation Thérapeutique du Généraliste
ClinicalTrials.gov Identifier:
NCT00398944
First received: November 13, 2006
Last updated: July 26, 2010
Last verified: November 2006
  Purpose

The purpose is to determine wether an electronic decision support system based on national guidelines is effective to improve the follow-up and the treatment of two conditions: hypertension and diabetes, in primary care practices.


Condition Intervention
Diabetes Mellitus
Hypertension
Device: Evaluation of the impact of a guideline based computerized decision support system.

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Impact of a Computerized Decision Support System, Based on EBM French Guidelines, on the Management of Hypertension and Diabetes: a Randomised Controlled Trial in Primary Care

Resource links provided by NLM:


Further study details as provided by Société de Formation Thérapeutique du Généraliste:

Primary Outcome Measures:
  • Patients who underwent the recommended procedures during the last 12 months [ Time Frame: 16 months ] [ Designated as safety issue: No ]

Enrollment: 2715
Study Start Date: November 2006
Study Completion Date: May 2008
Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Detailed Description:

Existing computer-based ordering systems for physicians provide drug-centred checks but offer little assistance for optimizing the overall patient-centred treatment strategy.

The ASTI project aims :

  1. to design a guideline-based decision support system for diabetic and/or hypertensive patients, to help general practitioners :

    1. to carry out procedures (clinical and biological tests) according to guidelines (the recommended procedure at the recommended moment), and to get a synthetic view of all the elements they need to follow-up the patient
    2. to avoid prescription errors and to improve compliance with therapeutic guidelines. The " critic mode " operates as a background process and corrects the physician's prescription on the basis of automatically triggered elementary rules that account for isolated guideline recommendations. The " guided mode " directs the physician to the best treatment by browsing a comprehensive guideline knowledge base represented as a decision tree.
  2. To measure the impact of ASTI when it is implemented with an electronic medical record system. We adopt a randomized design, with the practice as the unit of randomization.
  Eligibility

Ages Eligible for Study:   25 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Hypertension
  • Mellitus diabetes
  • Follow-up by GP's
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00398944

Locations
France
SFTG
Paris, France, 75013
Sponsors and Collaborators
Société de Formation Thérapeutique du Généraliste
Investigators
Principal Investigator: Hector FALCOFF Société de Formation Thérapeutique du Généraliste
  More Information

Publications:
Responsible Party: Doctor Hector Falcoff, Société de Formation Thérapeutique du Généraliste
ClinicalTrials.gov Identifier: NCT00398944     History of Changes
Other Study ID Numbers: SFTG1968A
Study First Received: November 13, 2006
Last Updated: July 26, 2010
Health Authority: France: Ministry of Health

Keywords provided by Société de Formation Thérapeutique du Généraliste:
Guideline based decision support system, Hypertension, Diabetes

Additional relevant MeSH terms:
Diabetes Mellitus
Hypertension
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on April 16, 2014